FDA Adverse Event Malfunction Summary report: N

LITHIUM

MDR report key: 2088566 · Received May 13, 2011

Report

Report Number
1823260-2011-02602
Event Type
Malfunction
Date Received
May 13, 2011
Date of Event
April 7, 2011
Report Date
May 6, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
NDW
PMA / PMN Number
K063684
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA. THIS EVENT OCCURRED IN (B)(6). PRECISION CHECKS WERE PERFORMED WITH THE %CV WITHIN SPECIFICATIONS. THE GEAR PUMP PRESSURE WAS CHECKED AND FOUND TO BE ON THE LOW SIDE. IT WAS ADJUSTED TO WITHIN SPECIFICATIONS.

Additional Manufacturer Narrative · 1

A SPECIFIC ROOT CAUSE COULD NOT BE DETERMINED. THERE WAS NO EVIDENCE OF SAMPLE OR REAGENT CARRYOVER. NO APPLICATION OR REAGENT RELATED ISSUE COULD BE IDENTIFIED.

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA. THIS EVENT OCCURRED IN (B)(6). OTHER: NA.

Description of Event or Problem · 1

THE CUSTOMER EXPERIENCED AN ONGOING ISSUE WITH QUESTIONABLE LITHIUM RESULTS FROM THE COBAS 6000 C501 MODULE, (B)(4), SINCE (B)(6) 2011. DATA WAS PROVIDED FOR THREE PATIENT SAMPLES, OF WHICH THE RESULTS FOR TWO WERE DISCREPANT. PATIENT SAMPLE 1 INITIAL LITHIUM RESULT WAS 1.70 MMOL/L. THE SAMPLE WAS REPEATED THREE TIMES WITH RESULTS OF 0.68, 0.66, AND 0.64 MMOL/L. ALL RESULTS WERE ACCOMPANIED BY DATA FLAGS. ON (B)(6) 2011, PATIENT SAMPLE 2 INITIAL LITHIUM RESULT WAS 1.70 MMOL/L. THE SAMPLE WAS REPEATED THREE TIMES WITH RESULTS OF 0.75, 0.76, AND 0.76 MMOL/L. ALL RESULTS WERE ACCOMPANIED BY DATA FLAGS. IT IS UNKNOWN WHICH RESULTS, IF ANY, WERE REPORTED OUTSIDE THE LABORATORY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LITHIUM ASSAY, PORPHYRIN, SPECTROPHOTOMETRY, LITHIUM NDW ROCHE DIAGNOSTICS NA 61733301

Patients

Seq Age Sex Outcome Treatment
1